summit clinical trial tirzepatide JACC - #ACC25: A recent #JACC publication on the evaluates in patients with #HFpEF, with secondary analyses focusing on (1) cardiac structure and (2) #CKD. https://bit.ly/3EdDCQK SURPASS to SURMOUNT: The Tirzepatide

Severe kidney impairment (eGFR below 15 mL/min/1.73m) requires specialized medical evaluation before starting

If a label makes big claims but offers zero sourcing or testing detail, that's a reasonable reason to keep shopping

As per the ICMR-INDIAB study conducted between October 2008 and December 2020, the overall weighted prevalence of diabetes was 11.4%19

Talk to your doctor about over-the-counter anti-diarrheal, laxatives, or anti-nausea medications, depending on what side effects youre experiencing

DISCUSSION In this systematic review and meta-analysis, semaglutide demonstrated significant histologic improvements, with a higher likelihood of NASH resolution and improved NAS components, but it did not significantly improve fibrosis stage compared to placebo

Canadian Press health coverage receives support through a partnership with the Canadian Medical Association